Page 133 - FINAL PROGRAM

Early pregnancy
P-096 Genotyping analysis of protein S-Tokushima and the involvement of protein S antigen and activity in patients with recurrent pregnancy loss
Y. Matsukawa (Japan)
P-097 Ef cacy of intrauterine injection of granulocyte colony stimulating factor(G-CSF) on treatment of unexplained recurrent miscarriage
S. Zafardoust (Iran)
P-098 TSHR as a new susceptibility locus: The rst genome-wide association study for obstetric antiphospholipid syndrome
M. Sugiura-Ogasawara (Japan)
P-099 Local injection of diluent vasopressin followed by suction curettage as initial treatment of cervical ectopic pregnancy
H. Ishikawa (Japan)
P-100 The association between rst trimester uterine artery Doppler velocimetry indices and adverse perinatal outcomes in IVF cycles
H. Timur (Turkey)
P-101 Area under the curve of estradiol monitorisation: A novel approach to evaluate detrimental effect of estrogen exposure on implantation along the COH
T. Kutlu (Turkey)
P-102 Optimism in live birth rates of unicornuate uterus patients
H. Bulut (Turkey)
P-103 HLA-E was involved in the effect of progesterone on the ADAM19 expression in JEG-3 cells
H. Zhongying (China)
P-104 Expression of hypoxia inducible factor and vascularization status was altered in peri- implantation endometrium of women with recurrent miscarriage
Y. Liu (Hong Kong)
P-105 Flow cytometric evaluation of epithelial b3-Integrin expression in endometrium of recurrent miscarriage patients and correlation with endometrial receptivity array
K. Marron (Ireland)
P-106 A one year retrospective analysis comparing live birth outcomes from embryos grown and transferred from an undisturbed time-lapse culture system with a conventional culture system
K. McEvoy (United Kingdom)
P-107 Spontaneous abortion rates are decreased by using sperms following annexin V magnetic activated cell sorting (MACS) in ART for recurrent miscarriage patients
H.C. Kwon (Korea, South)
FINAL PROGRAMME I HELSINKI, FINLAND – 3 TO 6 JULY 2016 129
POSTERS